BioMarin Pharmaceutical (NasdaqGS:BMRN) Q1 2026 Earnings call May 04, 2026 04:30 PM ET Company ParticipantsAlexander Hardy - President and CEOBrian Mueller - EVP and CFOChris Raymond - Managing Director, Equity ResearchCristin Hubbard - EVP and Chief Commercial OfficerGreg Friberg - EVP, Chief Research and Development OfficerJason Gerberry - Managing DirectorJoseph Schwartz - Director, BiotechnologyPaul Matteis - Managing Director and Head of Biotech ResearchTraci McCarty - Group VP of Investor RelationsCon ...